Anticoagulant Sodium Citrate (Medsep Corporation)
Welcome to the PulseAid listing for the Anticoagulant Sodium Citrate drug offered from Medsep Corporation. This Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Medsep Corporation |
| NON-PROPRIETARY NAME: | Sodium Citrate |
| SUBSTANCE NAME: | SODIUM CITRATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2011-04-15 |
| END MARKETING DATE: | 0000-00-00 |
Anticoagulant Sodium Citrate HUMAN PRESCRIPTION DRUG Details:
| Item Description | Anticoagulant Sodium Citrate from Medsep Corporation |
| LABELER NAME: | Medsep Corporation |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 10(g/250mL) |
| START MARKETING DATE: | 2011-04-15 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 62646-798_a083fb8e-3012-4d12-94d3-949a3188aba3 |
| PRODUCT NDC: | 62646-798 |
| APPLICATION NUMBER: | NDA760305 |
Other SODIUM CITRATE Pharmaceutical Manufacturers / Labelers:
